Navigation Links
Blue Marble Biomaterials Secures Distribution Agreement with SAFC
Date:1/23/2013

Missoula, Montana, USA (PRWEB) January 23, 2013

Blue Marble Biomaterials, a specialty biochemical manufacturer founded in Seattle, Washington and based in Missoula, Montana, has secured an exclusive distribution contract with Sigma-Aldrich® Corporation’s custom manufacturing and services business unit, SAFC®. As a global manufacturer and distributor of specialty chemicals used in a wide variety of industries including food and beverage flavors, personal care ingredients, scientific research, biotechnology and pharmaceuticals, the agreement gives SAFC’s customers ready access to Blue Marble’s offer of natural and sustainable biochemical alternatives. These products will be sold under the SAFC portfolio and are expected to be available for purchase in April of 2013.

“We are excited to announce this agreement with SAFC. Over the past several months, we worked closely together to develop a comprehensive strategy to offer our all-natural, drop-in replacement biochemicals to its customers. In 2010, twenty percent of all chemicals sold globally were sustainable. By 2025, the United States Department of Agriculture predicts that 45 to 50% of all chemicals sold will be sustainable. This relationship helps to illustrate the trend that is occurring with natural biochemicals and through this agreement with Blue Marble, SAFC has the potential to be the market frontrunner in offering natural biochemicals to its customers,” said Colby Underwood, Co-CEO and Chief Business Officer for Blue Marble Biomaterials.

About Blue Marble Biomaterials: Blue Marble Biomaterials is a wholly owned subsidiary of Blue Marble Energy. Blue Marble Biomaterials manufactures renewable specialty chemicals for the food, fragrance, cosmetics, and personal care industries in a zero-waste, carbon neutral production facility in Missoula, Montana. Their mission is to replace petroleum-based chemicals with fully sustainable, zero carbon specialt
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biomaterials China News 1210 - Annual Subscription
2. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
3. The Alliance for Regenerative Medicine forms Tissue Engineering and Biomaterials Committee
4. LA Dental Bone Graft Substitute & Other Biomaterials Market Reviewed in New iData Research Report Available at MarketPublishers.com
5. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
6. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
7. Roka Bioscience Secures $47.5 Million in Series D Financing
8. Generex Secures Commitments for $3.6M Capital Raise
9. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
10. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
11. Bacterin Secures $25 Million Financing with OrbiMed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by Instrument (Liquid ... Valves, Guages, Seals), Accessories, Services, End User (Biotechnology, ... provides a detailed overview of the major drivers, ... impacting the preparative and process chromatography market along ...
(Date:12/24/2014)... December 23, 2014 Earlier this year in ... director of the Adult Stem Cell Technology Center, LLC ( ... appreciated unique property of adult tissue stem cells. His ... Past, Important for the Future,” embodied the essence of his ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... Novel system is the first to use rapid, automated DNA ... ... Inc., a leader in the,development of state of the art ... the United States Patent,and Trademark Office (USPTO) recently issued U.S. ...
... Expression Genetics, Inc.,(EGEN) announced today that ... selected as one of the Top 10 ... strategic partnering. The selection was made by,an ... leading,provider of business information products and services ...
... Bio-,Pharmaceutical Technology, Inc (OTC Bulletin Board: HFGB) (the ... and pharmaceutical raw,materials for use in pharmaceutical, nutraceutical ... announce a Letter of Intent to enter into ... ("Qinba").,Under the proposed terms of this arrangement, Huifeng ...
Cached Biology Technology:eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections 2eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections 3Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 2Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 3Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd. 2
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014  Since its launch in ... of people to eliminate the pain of trying to remember ... their own biometrics fused to their smartphones. To assist people ... Labs , the company that created 1U and focuses on ...
(Date:12/22/2014)...  The 2014 Holiday Season may be the brightest ever ... that the long anticipated floodgates for consumer biometrics may ... smart phones, tablets, and wearable mobile devices that incorporate ... users with nearly 4.8 billion biometric devices by 2020.   ...
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal genetics company, ... differences in genetic ancestry of individuals from across ... arrived more than four hundred years ago, the ... for peoples from different continents. This study illuminates how American ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... Institute of Marine Science continue to monitor the algal blooms ... few weeks. These "red tides" occur in the lower Bay ... area than in years past, likely due to last winter,s ... by dense blooms of tiny marine plants called algae that ...
... , PROVIDENCE, R.I. [Brown University] Policymakers struggling to ... questions on the scale of millions of people and ... the impact of many potential interventions, alone or in ... 2012 International AIDS Society Conference in Washington, D.C., Brandon ...
... Ethical Treatment of Animals (PETA) Foundation UK has submitted ... the European Chemicals Agency (ECHA) is failing to fulfil ... which animal testing could be avoided under the rules ... in EU institutions and agencies, and PETA maintains that ...
Cached Biology News:Researchers monitor 'red tides' in Chesapeake Bay 2Computers can predict effects of HIV policies 2Computers can predict effects of HIV policies 3PETA files complaint with European ombudsman over animal testing for REACH 2
... Caspase-9 Pan-Caspase In Situ Assay Kit, Fluorescein ... active caspases in cells undergoing apoptosis. The ... for use in diagnostic or therapeutic procedures. ... use a novel approach to detect active ...
... silencing experiments often call for critical, ... Transfection Agent refines siRNA transfection protocols ... lipid-based formulation can be used to ... are subcultured without increased cytotoxicity. ...
... as well as other yeasts, has become ... laboratories. The ability to transform whole cells ... DNAs using lithium based buffers and polyethylene ... library screening easy and reliable, especially when ...
...
Biology Products: